Celltrion’s Remsima SC Will No Longer Need IV Loading

EMA Committee Endorses Direct Subcutaneous Use Of Infliximab Biosimilar

No Loading Sign Brick Wall
No intravenous loading will be required ahead of subcutaneous administration • Source: Shutterstock

More from Biosimilars

More from Products